24
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease

      research-article
      1 , 2 , 1 , 1 , 1 , 1 , 1 , GERAD/PERADES, CHARGE, ADGC, EADI, IGAP consortia, 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 15 , 17 , 18 , 17 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 19 , 26 , 1 , 27 , 2 , 2 , 1 , 2 , 2 , 28 , 29 , 30 , 1 , 2 , * , 1 , 2 , *
      PLoS ONE
      Public Library of Science

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Late onset Alzheimer’s disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is to identify novel genes associated with Alzheimer’s disease using the largest up-to-date reference single nucleotide polymorphism (SNP) panel, the most accurate imputation software and a novel gene-based analysis approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer’s Project Consortium, comprising over 7 million genotypes from 17,008 Alzheimer’s cases and 37,154 controls. In addition to earlier reported genes, we detected three novel gene-wide significant loci PPARGC1A ( p = 2.2 × 10 −6), RORA ( p = 7.4 × 10 −7) and ZNF423 ( p = 2.1 × 10 −6). PPARGC1A and RORA are involved in circadian rhythm; circadian disturbances are one of the earliest symptoms of Alzheimer’s disease. PPARGC1A is additionally linked to energy metabolism and the generation of amyloid beta plaques. RORA is involved in a variety of functions apart from circadian rhythm, such as cholesterol metabolism and inflammation. The ZNF423 gene resides in an Alzheimer’s disease-specific protein network and is likely involved with centrosomes and DNA damage repair.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism.

          The mammalian clock regulates major aspects of energy metabolism, including glucose and lipid homeostasis and mitochondrial oxidative metabolism. The biochemical basis for coordinated control of the circadian clock and diverse metabolic pathways is not well understood. Here we show that PGC-1alpha (Ppargc1a), a transcriptional coactivator that regulates energy metabolism, is rhythmically expressed in the liver and skeletal muscle of mice. PGC-1alpha stimulates the expression of clock genes, notably Bmal1 (Arntl) and Rev-erbalpha (Nr1d1), through coactivation of the ROR family of orphan nuclear receptors. Mice lacking PGC-1alpha show abnormal diurnal rhythms of activity, body temperature and metabolic rate. The disruption of physiological rhythms in these animals is correlated with aberrant expression of clock genes and those involved in energy metabolism. Analyses of PGC-1alpha-deficient fibroblasts and mice with liver-specific knockdown of PGC-1alpha indicate that it is required for cell-autonomous clock function. We have thus identified PGC-1alpha as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

            Background Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified the first strongly supported LOAD susceptibility genes since the discovery of the involvement of APOE in the early 1990s. We have now exploited these GWAS datasets to uncover key LOAD pathophysiological processes. Methodology We applied a recently developed tool for mining GWAS data for biologically meaningful information to a LOAD GWAS dataset. The principal findings were then tested in an independent GWAS dataset. Principal Findings We found a significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response in both of the two largest genome-wide association studies for LOAD. Significance Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process. Our independent evidence from two large studies now demonstrates that these processes are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

              To explore mechanisms through which altered peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) expression may influence Alzheimer disease (AD) amyloid neuropathology and to test the hypothesis that promotion of PGC-1alpha expression in neurons might be developed as a novel therapeutic strategy in AD. Case-control. Patients Human postmortem brain (hippocampal formation) samples from AD cases and age-matched non-AD cases. Using genome-wide complementary DNA microarray analysis, we found that PGC-1alpha messenger RNA expression was significantly decreased as a function of progression of clinical dementia in the AD brain. Following confirmatory real-time polymerase chain reaction assay, we continued to explore the role of PGC-1alpha in clinical dementia and found that PGC-1alpha protein content was negatively associated with both AD-type neuritic plaque pathology and beta-amyloid (Abeta)(X-42) contents. Moreover, we found that the predicted elevation of amyloidogenic Abeta(1-42) and Abeta(1-40) peptide accumulation in embryonic cortico-hippocampal neurons derived from Tg2576 AD mice under hyperglycemic conditions (glucose level, 182-273 mg/dL) coincided with a dose-dependent attenuation in PGC-1alpha expression. Most importantly, we found that the reconstitution of exogenous PGC-1alpha expression in Tg2576 neurons attenuated the hyperglycemic-mediated beta-amyloidogenesis through mechanisms involving the promotion of the "nonamyloidogenic" alpha-secretase processing of amyloid precursor protein through the attenuation of the forkheadlike transcription factor 1 (FoxO3a) expression. Therapeutic preservation of neuronal PGC-1alpha expression promotes the nonamyloidogenic processing of amyloid precursor protein precluding the generation of amyloidogenic Abeta peptides.
                Bookmark

                Author and article information

                Contributors
                Role: Formal analysisRole: MethodologyRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Funding acquisitionRole: SupervisionRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: SupervisionRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                2019
                8 July 2019
                : 14
                : 7
                : e0218111
                Affiliations
                [1 ] Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom
                [2 ] UK Dementia Research Institute at Cardiff University, Cardiff, United Kingdom
                [3 ] Human Genetics, School of Life Sciences, Life Sciences Building A27, University Park, University of Nottingham, Nottingham, NG7 2RD, United Kingdom
                [4 ] Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University, Belfast, United Kingdom
                [5 ] Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, United Kingdom
                [6 ] Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom
                [7 ] Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
                [8 ] Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
                [9 ] Mercer’s Institute for Research on Ageing, St. James’ Hospital, Dublin, Ireland
                [10 ] James Hospital and Trinity College, Dublin, Ireland
                [11 ] MRC Prion Unit at UCL, Institute of Prion Diseases, London, United Kingdom
                [12 ] Experimental Neuropsychobiology Laboratory, IRCCS Santa Lucia Foundation, Department of Clinical and Behavioral Neurology, Rome, Italy
                [13 ] Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
                [14 ] Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
                [15 ] Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St Louis, Missouri, United States of America
                [16 ] Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America
                [17 ] German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany
                [18 ] Department of Psychiatry and Psychotherapy, University of Bonn, 53127, Bonn, Germany
                [19 ] Department of Psychiatry and Psychotherapy, University of Cologne, 50937 Cologne, Germany
                [20 ] Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany
                [21 ] German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
                [22 ] Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany
                [23 ] German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, 80336, Germany
                [24 ] Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
                [25 ] Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
                [26 ] Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
                [27 ] Department of Molecular Neuroscience, UCL, Institute of Neurology, London, United Kingdom
                [28 ] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America
                [29 ] Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
                [30 ] Univ. Lille, Inserm, CHU Lille University Hospital, Institut Pasteur de Lille, LabEx DISTALZ-UMR1167 - RID-AGE - Risk factors and molecular determinants of aging-related, F-59000 Lille, France
                University of Ioannina Medical School, GREECE
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                ¶ For more information on these consortia and their full membership lists, please see the Acknowledgments and S1 Appendix.

                Author information
                http://orcid.org/0000-0001-5691-597X
                http://orcid.org/0000-0003-3239-8415
                http://orcid.org/0000-0001-5307-663X
                http://orcid.org/0000-0002-4326-1468
                http://orcid.org/0000-0003-4991-763X
                http://orcid.org/0000-0001-6271-6301
                http://orcid.org/0000-0001-6776-8709
                http://orcid.org/0000-0003-0870-9412
                http://orcid.org/0000-0003-1115-2475
                Article
                PONE-D-19-01465
                10.1371/journal.pone.0218111
                6613773
                31283791
                fd81aa75-0666-4bf9-8edf-600915c30d7b
                © 2019 Baker et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 16 January 2019
                : 27 May 2019
                Page count
                Figures: 1, Tables: 1, Pages: 11
                Funding
                We thank the MRC Centre for Neuropsychiatric Genetics and Genomics for supporting this project and the MRC for supporting author EB. This project was also supported by the UK Dementia Research Institute. We would like to acknowledge the grants supporting the following authors: UKDRI (UKDRIdata023) EB, DI, MH, NDA, BPM, JW, VEP; MRC Centre for Neuropsychiatric Genetics and Genomics (MR/L010305/1) EB, RS, GL, JH, DG, LJ, PH, VEP; Dementia Platforms UK- DPUK (MR/L023784/2) JH, GL, VEP, JW, DG.
                Categories
                Research Article
                Medicine and Health Sciences
                Mental Health and Psychiatry
                Dementia
                Alzheimer's Disease
                Medicine and Health Sciences
                Neurology
                Dementia
                Alzheimer's Disease
                Medicine and Health Sciences
                Neurology
                Neurodegenerative Diseases
                Alzheimer's Disease
                Biology and Life Sciences
                Biochemistry
                Proteins
                Lipoproteins
                Apolipoprotein Genes
                Biology and Life Sciences
                Genetics
                Gene Expression
                Biology and Life Sciences
                Genetics
                Gene Expression
                Gene Regulation
                Biology and Life Sciences
                Computational Biology
                Genome Analysis
                Genome-Wide Association Studies
                Biology and Life Sciences
                Genetics
                Genomics
                Genome Analysis
                Genome-Wide Association Studies
                Biology and Life Sciences
                Genetics
                Human Genetics
                Genome-Wide Association Studies
                Social Sciences
                Sociology
                Consortia
                Biology and Life Sciences
                Chronobiology
                Circadian Rhythms
                Biology and Life Sciences
                Genetics
                Molecular Genetics
                Biology and Life Sciences
                Molecular Biology
                Molecular Genetics
                Custom metadata
                IGAP data can be downloaded from the following website: http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php Summary data relating to GERAD consortium are available to request by contacting ADresearchoffice@ 123456cardiff.ac.uk .

                Uncategorized
                Uncategorized

                Comments

                Comment on this article